| Literature DB >> 26343712 |
Yanru Hao1, Subao Tian2, Xiaohui Jiao3, Na Mi4, Bing Zhang5, Tao Song6, Le An7, Xudong Zheng8, Deshu Zhuang9.
Abstract
The aim of present study was to check the possible association of potential parental environmental exposures and maternal supplementation intake with the risk of nonsyndromic orofacial clefting (NSOC). A retrospective study comprised 499 cases and 480 controls was conducted in Heilongjiang Province. Chi-square analysis and unconditional multiple logistic regression were used in the study. The results showed that maternal history of fever and the common cold without fever (ORCL/P = 3.11 and 5.56, 95%CI: 1.67-5.82 and 2.96-10.47, ORCPO = 3.31 and 8.23, 95%CI: 1.58-6.94 and 4.08-16.95), paternal smoking and alcohol consumption (ORCL/P = 2.15 and 5.04, 95%CI: 1.37-3.38 and 3.00-8.46, ORCPO = 1.82 and 4.40, 95%CI: 1.06-3.13 and 2.50-7.74), maternal exposure to organic solvents, heavy metals, or pesticides (ORCL/P = 6.07, 5.67 and 5.97, 95%CI: 1.49-24.76, 1.34-24.09 and 2.10-16.98, ORCPO = 10.65, 7.28 and 3.48, 95%CI: 2.54-44.67, 1.41-37.63 and 1.06-11.46) and multivitamin use during the preconception period (ORCL/P = 0.06, 95%CI: 0.02-0.23, ORCPO = 0.06, 95%CI: 0.01-0.30) were associated with cleft lip or without cleft palate (CL/P) and cleft palate only (CPO). Maternal history of skin disease and negative life events (ORCL/P = 12.07 and 1.67, 95%CI: 1.81-80.05 and 1.95-2.67) were associated with CL/P. Some potential parental hazardous exposures during the periconception period and maternal use of multivitamins during the preconception period were associated with risk of NSOC.Entities:
Keywords: environmental exposures; folic acid; multivitamin use; nonsyndromic orofacial clefts; passive smoking; toxic occupational exposure
Mesh:
Substances:
Year: 2015 PMID: 26343712 PMCID: PMC4586523 DOI: 10.3390/nu7095328
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic characteristics of 499 case and 480 control parents.
| Characteristics | Control | CL/P OR (95%CI) | CPO OR (95%CI) | ||||
|---|---|---|---|---|---|---|---|
| Maternal gestational age | <0.001 | <0.001 | |||||
| <20 | 8 (1.67%) | 16 (4.4%) | 1.85 (0.77–4.43) | 8 (5.8%) | 2.79 (1.00–7.75) | ||
| 20–24 | 173 (36.0%) | 187 (51.7%) | Ref. | 62 (45.3%) | Ref. | ||
| 25–29 | 229 (47.7%) | 85 (23.5%) | 0.34 (0.25–0.48) | 36 (26.3%) | 0.44 (0.28–0.69) | ||
| 30–34 | 58 (12.1%) | 39 (10.8%) | 0.62 (0.39–0.98) | 22 (16.1%) | 1.06 (0.60–1.87) | ||
| ≥35 | 12 (2.5%) | 35 (9.6%) | 2.70 (1.36–5.37) | 9 (6.5%) | 2.09 (0.84–5.21) | ||
| Maternal education | <0.001 | <0.001 | |||||
| Primary or junior high school | 172 (35.8%) | 319 (88.1%) | 8.04 (5.42–11.92) | 110 (80.3%) | 4.70 (2.86–7.72) | ||
| High school or technical school | 169 (35.2%) | 39 (10.8%) | Ref. | 23 (16.8%) | Ref. | ||
| University or higher | 139 (29.0%) | 4 (1.1%) | 0.13 (0.04–0.36) | 4 (2.9%) | 0.21 (0.07–0.63) | ||
| Paternal education | <0.001 | <0.001 | |||||
| Primary or junior high school | 161 (33.5%) | 315 (87.0%) | 9.03 (6.08–13.40) | 111 (81.0%) | 8.27 (4.63–14.78) | ||
| High school or technical school | 180 (37.5%) | 39 (10.8%) | Ref. | 15 (10.9%) | Ref. | ||
| University or higher | 139 (29.0%) | 8 (2.2%) | 0.27 (0.12–0.59) | 11 (8.1%) | 0.95 (0.42–2.13) | ||
| Household annual income | <0.001 | <0.001 | |||||
| <¥10,000 | 100 (20.8%) | 173 (47.8%) | 1.94 (1.39–2.70) | 58 (42.3%) | 1.90 (1.21–2.98) | ||
| ¥10,000–30,000 | 167 (34.8%) | 149 (41.2%) | Ref. | 51 (37.2%) | Ref. | ||
| ≥¥30,000 | 213 (44.4%) | 40 (11.0%) | 0.21 (0.14–0.32) | 28 (20.5%) | 0.43 (0.26–0.71) | ||
| Gender of infant | <0.001 | 0.002 | |||||
| Male | 245 (51.0%) | 250 (69.1%) | Ref. | 49 (35.8%) | Ref. | ||
| Female | 235 (49.0%) | 112 (30.9%) | 0.47 (0.35–0.62) | 88 (64.2%) | 1.87 (1.26–2.77) | ||
| Gravidity | <0.001 | <0.001 | |||||
| 1 | 309 (64.4%) | 164 (45.3%) | Ref. | 59 (43.1%) | Ref. | ||
| 2 | 116 (24.2%) | 115 (31.8%) | 1.87 (1.36–2.57) | 47 (34.3%) | 2.12 (1.37–3.29) | ||
| ≥3 | 55 (11.4%) | 83 (22.9%) | 2.84 (1.93–4.20) | 31 (22.6%) | 2.95 (1.95–4.97) | ||
| Negative reproductive history a | 0.002 | <0.001 | |||||
| no | 345 (71.9%) | 223 (61.6%) | Ref. | 74 (54.0%) | Ref. | ||
| yes | 135 (28.1%) | 139 (38.4%) | 1.59 (1.91–2.13) | 63 (46.0%) | 2.18 (1.47–3.22) | ||
| Body mass index (kg/m2) | 0.004 | 0.555 | |||||
| <18 | 58 (12.1%) | 62 (17.1%) | 1.64 (1.11–2.42) | 23 (16.8%) | 1.46 (0.86–2.49) | ||
| 18–24 | 384 (80%) | 251 (69.3%) | Ref. | 104 (75.9%) | Ref. | ||
| 25–29 | 31 (6.5%) | 42 (11.6%) | 2.07 (1.27–3.39) | 8 (5.8%) | 0.95 (0.43–2.14) | ||
| ≥30 | 7 (1.4%) | 7 (2.0%) | 1.54 (0.53–4.41) | 2 (1.5%) | 1.06 (0.22–5.15) |
CL/P, cleft lip with or without cleft palate; CPO, cleft palate only; a history of induced abortion, spontaneous abortion and stillbirth; Statistical significance values are given in bold.
Maternal health factors, occupational exposures, and parental lifestyle factors of cases and controls during the first trimester.
| Factors | Control
| CL/P
| OR (95%CI) | CPO
| OR (95%CI) | ||
|---|---|---|---|---|---|---|---|
| Maternal illness | |||||||
| History of fever | 46 (9.6%) | 79 (21.8%) | <0.001 | 2.63 (1.78, 3.90) | 27 (19.7%) | 0.004 | 2.32 (1.38, 3.89) |
| Cold without fever | 36 (7.5%) | 120 (33.1%) | <0.001 | 6.06 (4.05, 9.09) | 48 (35.0%) | <0.001 | 6.65 (4.08, 10.84) |
| History of skin disease | 3 (0.6%) | 15 (4.1%) | 0.005 | 6.87 (1.97, 23.92) | 4 (2.9%) | 0.050 | 4.78 (1.06, 21.63) |
| Medication use | |||||||
| Antipyretics or analgesic a | 13 (2.7%) | 34 (9.4%) | <0.001 | 3.72 (1.93, 7.16) | 15 (10.9%) | <0.001 | 4.42 (2.05, 9.53) |
| Anti-infectious drugs b | 20 (4.2%) | 74 (20.4%) | <0.001 | 5.91 (3.93, 9.90) | 30 (21.9%) | <0.001 | 6.45 (3.53, 11.79) |
| Topical corticosteroids | 2 (0.4%) | 12 (3.3%) | 0.008 | 8.19 (1.82, 36.82) | 3 (2.2%) | 0.092 | 5.35 (0.88, 32.34) |
| Lifestyle factors | |||||||
| Maternal smoking | 28 (5.8%) | 26 (7.2%) | 0.452 | 1.25 (0.72, 2.17) | 9 (6.6%) | 0.750 | 1.14 (0.52, 2.47) |
| Paternal smoking | 197 (41.0%) | 218 (60.2%) | <0.001 | 2.17 (1.65, 2.87) | 82 (59.9%) | <0.001 | 2.14 (1.45, 3.15) |
| Maternal passive smoking | 175 (36.5%) | 214 (59.1%) | <0.001 | 2.52 (1.90, 3.33) | 71 (51.8%) | 0.002 | 1.87 (1.28, 2.75) |
| Maternal alcohol consumption | 72 (15.0%) | 43 (11.9%) | 0.177 | 0.75 (0.50, 1.12) | 26 (19.0%) | 0.376 | 1.28 (0.77, 2.11) |
| Paternal alcohol consumption | 74 (15.4%) | 170 (47.0%) | <0.001 | 4.86 (3.52, 6.70) | 66 (48.2%) | <0.001 | 5.02 (3.31, 7.63) |
| Maternal negative life events | 32 (27.5%) | 179 (49.4%) | <0.001 | 2.56 (1.92, 3.42) | 69 (50.4%) | <0.001 | 2.66 (1.81, 3.90) |
| Maternal occupational exposure | |||||||
| Organic solvents | 8 (1.7%) | 22 (6.1%) | 0.002 | 3.82 (1.68, 8.67) | 16 (11.7%) | <0.001 | 7.80 (3.26, 18.66) |
| Heavy metals | 7 (1.5%) | 34 (9.4%) | <0.001 | 7.00 (3.07, 15.99) | 12 (8.8%) | <0.001 | 6.48 (2.50, 16.81) |
| Pesticides | 5 (1.0%) | 73 (20.2%) | <0.001 | 23.99 (9.58, 60.06) | 21 (15.3%) | <0.001 | 17.20 (6.35, 46.60) |
a aspirin, acetaminophen; b antibiotics, antimycotics, antiviral drugs, antihelminthics; OR, odds ratio; CI, confidence interval; Statistical significance values are given in bold.
Maternal supplementation intake during the preconception period or the first trimester in case and control group.
| Supplementation | Control | CL/P | OR (95%CI) | CPO | OR (95%CI) | ||
|---|---|---|---|---|---|---|---|
| Folic acid | |||||||
| Any use during preconception period a | 30 (6.3%) | 10 (2.8%) | 0.025 | 0.43 (0.21, 0.88) | 6 (4.4%) | 0.431 | 0.69 (0.28, 1.69) |
| Any use during first trimester | 97 (24.9%) | 67 (18.5%) | 0.590 | 0.91 (0.64, 1.29) | 34 (24.9%) | 0.257 | 1.32 (0.84, 2.07) |
| Multivitamins | |||||||
| Any use during preconception period a | 106 (28.3%) | 4 (1.1%) | <0.001 | 0.04 (0.01, 0.11) | 3 (2.2%) | <0.001 | 0.08 (0.02, 0.25) |
| Any use during first trimester | 85 (17.7%) | 47 (13.0%) | 0.070 | 0.69 (0.47, 1.02) | 15 (10.9%) | 0.084 | 0.57 (0.32, 1.03) |
| Cod liver oil | |||||||
| Any use during preconception period a | 30 (6.3%) | 1 (0.3%) | 0.002 | 0.04 (0.01, 0.31) | 1 (0.7%) | 0.048 | 0.11 (0.01, 0.82) |
| Any use during first trimester | 21 (4.4%) | 2 (0.6%) | 0.006 | 0.12 (0.03, 0.52) | 1 (0.7%) | 0.099 | 0.16 (0.02, 1.21) |
a preconception period means one month before conception; OR, odds ratio; CI, confidence interval; Statistical significance values are given in bold; CL/P, cleft lip with or without cleft palate; CPO, cleft palate only.
Multivariable logistic regression of case and control group.
| Factors | Control
| CL/P
| aOR (95%CI) | CPO
| aOR (95%CI) |
|---|---|---|---|---|---|
| History of fever | 46 (9.6%) | 79 (21.8%) | 3.11 (1.67, 5.82) | 27 (19.7%) | 3.31 (1.58, 6.94) |
| Common cold without fever | 36 (7.5%) | 120 (33.1%) | 5.56 (2.96, 10.47) | 48 (35.0%) | 8.23 (4.08, 16.59) |
| History of skin disease | 3 (0.6%) | 15 (4.1%) | 12.07 (1.81, 80.50) | 4 (2.9%) | - |
| Paternal smoking | 197 (41.0%) | 218 (60.2%) | 2.15 (1.37, 3.38) | 82 (59.9%) | 1.82 (1.06, 3.13) |
| Paternal alcohol consumption | 74 (15.4%) | 170 (47.0%) | 5.04 (3.00, 8.46) | 66 (48.2%) | 4.40 (2.50, 7.74) |
| Maternal negative life events | 32 (27.5%) | 179 (49.4%) | 1.67 (1.95, 2.67) | 69 (50.4%) | - |
| Organic solvents | 8 (1.7%) | 22 (6.1%) | 6.07 (1.49, 24.76) | 16 (11.7%) | 10.65 (2.54, 44.67) |
| Heavy metals | 7 (1.5%) | 34 (9.4%) | 5.67 (1.34, 24.09) | 12 (8.8%) | 7.28 (1.41, 37.63) |
| Pesticides | 5 (1.0%) | 73 (20.2%) | 5.97 (2.10, 16.98) | 21 (15.3%) | 3.48 (1.06, 11.46) |
| Any multivitamin use during preconception period | 106 (28.3%) | 4 (1.1%) | 0.06 (0.02, 0.23) | 3 (2.2%) | 0.06 (0.01, 0.30) |
OR, odds ratio; CI, confidence interval; aOR adjusted for maternal age, sexual of infants, parental education, annual household income, gravidity, maternal body mass index (BMI) and history of negative reproductive; CL/P, cleft lip with or without cleft palate; CPO, cleft palate only.